Literature DB >> 11340550

Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.

P Idigoras1, E Pérez-Trallero, L Piñeiro, J Larruskain, M C López-Lopategui, N Rodríguez, J M González.   

Abstract

Scedosporium prolificans infection was analyzed in 18 patients from whom the fungus was isolated during the period 1990-1999. Of these 18 patients, 12 had some predisposing factor and either unconfirmed infection or colonization, and 6 patients had confirmed disseminated infection: 4 patients with leukemia died, 1 patient with breast cancer who underwent autologous bone marrow transplantation survived, and 1 patient with advanced acquired immunodeficiency syndrome died, although the fungal infection did not seem to affect his clinical symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11340550     DOI: 10.1086/320521

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

Authors:  B P Howden; M A Slavin; A P Schwarer; A M Mijch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-14       Impact factor: 3.267

Review 2.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

3.  Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.

Authors:  Yotaro Ochi; Nobuhiro Hiramoto; Hiroshi Takegawa; Noboru Yonetani; Asako Doi; Chihiro Ichikawa; Yukihiro Imai; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

4.  Answer to October 2017 Photo Quiz.

Authors:  Puja H Nambiar; Mindy Tokarczyk; Joseph A DeSimone
Journal:  J Clin Microbiol       Date:  2017-10       Impact factor: 5.948

5.  In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Authors:  Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media.

Authors:  C C Blyth; A Harun; P G Middleton; S Sleiman; O Lee; T C Sorrell; W Meyer; S C A Chen
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

Review 7.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 8.  Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.

Authors:  Esther Benamu; Alexander Tin-Han Yu; Lijia Xie; Sebastian Fernandez-Pol; Anne Y Liu; Dora Y Ho
Journal:  Transpl Infect Dis       Date:  2017-12-21       Impact factor: 2.228

9.  Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.

Authors:  Laurence Delhaes; Azian Harun; Sharon C A Chen; Quoc Nguyen; Monica Slavin; Christopher H Heath; Krystyna Maszewska; Catriona Halliday; Vincent Robert; Tania C Sorrell; Wieland Meyer
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Infection with Scedosporium apiospermum and S. prolificans, Australia.

Authors:  Louise Cooley; Denis Spelman; Karin Thursky; Monica Slavin
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.